Hydantoin derivatives with affinity for somatostatin receptors

Details Hydantoin derivatives with affinity for somatostatin receptors Hydantoin derivatives with affinity for somatostatin receptors

2006-03-28

2006-03-28

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S254050, C514S323000, C514S339000, C514S391000, C544S139000, C544S373000, C546S201000, C548S305100, C548S306100, C548S311400, C548S312100

Reexamination Certificate

active

07019004

ABSTRACT:
The invention provides compounds of formula (I) wherein X, Y, R1, R2, R3and R4are as defined in the description, and the preparation thereof. The compounds of the formula bind to somatostatin receptors and are useful as pharmaceuticals

REFERENCES:
patent: 5859190 (1999-01-01), Meyer et al.
patent: 2003/0191134 (2003-10-01), Shapiro et al.
patent: WO 01/09090 (2001-02-01), None
patent: 2003/042234 (2003-05-01), None
Yang, Annual Reports in Medicinal Chemistry, vol. 34, p. 209-218 (1999).
Sciciński et al., “The Solid Phase Synthesis of a Series of Tri-Substituted Hydantoin Ligands for the Somatostatin SST5Receptor”,Bioorg. Med. Chem. Lett., vol. 8, No. 24, pp. 3609-3614 (1998).

Affiliated with

Also associated with

Rating

Hydantoin derivatives with affinity for somatostatin receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydantoin derivatives with affinity for somatostatin receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives with affinity for somatostatin receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3614822